Last reviewed · How we verify

NCT05334953

Efficacy of Extracorporeal Shock Wave Therapy, Ultrasound and Phonophoresis Treatments in Lateral Epicondylitis

Completed NA Last updated 10 January 2023
What this trial tests

NA trial testing ESWT in Lateral Epicondylitis in 68 participants. Completed in 6 January 2023.

Timeline
1 June 2022
Primary endpoint
15 September 2022
6 January 2023

Quick facts

Lead sponsorBezmialem Vakif University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment68
Start date1 June 2022
Primary completion15 September 2022
Estimated completion6 January 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Bezmialem Vakif University

Who can join

Adults 18 to 65, any sex, with Lateral Epicondylitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study; to determine the effectiveness of ESWT, ultrasound and phonophoresis treatments on pain, grip strength, functionality and quality of life in patients with lateral epicondylitis and to determine the superiority of the treatments to each other.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of ESWT

Trials testing the same drug.

Other recruiting trials for Lateral Epicondylitis

Currently open trials in the same condition.

Other Bezmialem Vakif University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05334953.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing